- BaxΔ2 sensitizes colorectal cancer cells to proteasome inhibitor-induced cell death
Adriana Mañas et al, 2018, Biochemical and Biophysical Research Communications CrossRef - LINC00461 Knockdown Enhances the Effect of Ixazomib in Multiple Myeloma Cells
Mingyang Deng et al, 2023, Current Cancer Drug Targets CrossRef - Clinical Pharmacology of Ixazomib: The First Oral Proteasome Inhibitor
Neeraj Gupta et al, 2019, Clinical Pharmacokinetics CrossRef - Revisiting Proteasome Inhibitors: Molecular Underpinnings of Their Development, Mechanisms of Resistance and Strategies to Overcome Anti-Cancer Drug Resistance
Carlota Leonardo-Sousa et al, 2022, Molecules CrossRef - An evolutionarily conserved ubiquitin ligase drives infection and transmission of flaviviruses
Linjuan Wu et al, 2024, Proceedings of the National Academy of Sciences CrossRef - Principles of Drug Metabolism and Interactions in Cardio‐Oncology
SHERRY‐ANN BROWN et al, 2022, Drug Metabolism Handbook CrossRef - Interactions between cardiology and oncology drugs in precision cardio-oncology
Sailaja Kamaraju et al, 2021, Clinical Science CrossRef